Find your next paid study

University of California, IrvineNCT06898658

Prandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein

The researchers overall objective is to determine whether plant and animal protein based proteins affect the anabolic responses across aging populations differ…

Protein Metabolism

Texas A&M UniversityNCT06628349

Wound HealDiabetic Foot Ulcer

A Multi-Centre, Observer-Blinded, Randomized Controlled Trial of EDX110 for the Treatment of Diabetic Foot Ulcers

Prospective, multi-centered, observer blinded, pre-market study, 1:1 randomized control trial, to determine if addition of EDX110 dressing system to standard o…

~$10 – $8,750

ConvaTec Inc.NCT07209358

Carcinoma, Hepatocellular

Randomized Study of Therapshere 90-Yittrium Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia

This clinical trial will compare 1-year outcomes in patients with hypoalbuminemia and a new diagnosis of small, early-stage hepatocellular carcinoma (HCC) who …

Ochsner Health SystemNCT05953961

Urologic CancerUrologic NeoplasmsBladder Cancer+5 more

A Pilot Study of a Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest for Surgical Dissection Within Urologic Regions of Interest.

This research study is a pilot clinical trial, which hypothesizes that the combination of electromagnetic tracking in conjunction with laparoscope imaging and …

Dana-Farber Cancer InstituteNCT05899361

~$10 – $7,500

APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System

This is a pilot evaluation of the APPRAISE trauma decision-support software system ("the System"). The specific objections are as follows: 1. Evaluate the rob…

Wounds and Injuries

Andrew Tomas ReisnerNCT06121661

~$10 – $7,500

Advanced Soft Tissue SarcomaMetastatic Soft Tissue Sarcoma

SAINT: A Phase 1/2 Study of Safe Amounts of IPLIMUMAB, NIVOLUMAB and TRABECTEDIN for Previously Treated Advanced Soft Tissue Sarcoma (STS)

This is an open label, dose-seeking phase 1/2 study using escalating doses of TRABECTEDIN given intravenously with defined doses of IPILIMUMAB and NIVOLUMAB ba…

Sarcoma Oncology Research Center, LLCNCT03138161

Phase 4

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

In this prospective, open-label, single-arm, single-institution trial, the investigators will accomplish the following two aims: 1. study the safety and toler…

Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remitting

Northwestern UniversityNCT07225361

Leukemia, Myeloid, AcuteLeukemia, B-cellLeukemia, T-Cell

Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)

This study is for patients who have a type of blood cancer that expresses the protein CD70, which includes acute myeloid leukemia (AML), T-cell leukemia or B-c…

Baylor College of MedicineNCT06345027

SarcomaHER-2 Protein OverexpressionOsteosarcoma+5 more

Phase I Study of HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma (HEROS 3.0)

The purpose of this study is to learn whether it is safe to give HER2-CAR T cells in combination with an immune checkpoint inhibitor drug (pembrolizumab or niv…

Baylor College of MedicineNCT04995003

Phase 4

Sex Differences in Trauma, Inflammation and Brain Function and the Implications for Treatment Efficacy in Alcohol Use Disorder

The goal of this clinical trial is to identify sex-specific biomarkers that confer greater susceptibility for Alcohol Use Disorder (AUD) and differentiate how …

Alcohol Use Disorder

ER-Positive Breast CancerHER2-negative Breast Cancer

~$10 – $7,500

Milky KohnoNCT06426303

Phase 2

Phase II Trial Of Fulvestrant Plus Abemaciclib In Er-Positive, Her2-Negative Metastatic Breast Cancer Immediately After Failure Of A Cdk4/6 Inhibitor

The study will investigate if CDK4/6 inhibitor holiday will reset the cell cycle process to respond to the combination of fulvestrant and abemaciclib, and this…